- Investing Ideas
- /
- U.S. Undervalued based on future growth
U.S. Undervalued based on future growth
Results
373
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
373 companies
Advanced Flower Capital
Market Cap: US$98.3m
Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry.
AFCG
US$4.35
7D
-4.6%
1Y
-50.3%
Mastech Digital
Market Cap: US$86.5m
Provides digital transformation IT services to large, medium-sized, and small companies in the United States.
MHH
US$7.35
7D
-9.1%
1Y
-8.1%
Outlook Therapeutics
Market Cap: US$82.7m
Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.
OTLK
US$1.93
7D
-5.4%
1Y
-73.7%
Heritage Global
Market Cap: US$76.5m
Operates as an asset services company with focus on financial and industrial asset transactions in the United States.
HGBL
US$2.17
7D
0.9%
1Y
-8.4%
Flexible Solutions International
Market Cap: US$65.6m
Develops, manufactures, and markets specialty chemicals that slow the evaporation of water in Canada, the United States, and internationally.
FSI
US$5.19
7D
8.6%
1Y
159.5%
Earth Science Tech
Market Cap: US$57.3m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.19
7D
-5.9%
1Y
28.9%
Snail
Market Cap: US$40.6m
Researches, develops, markets, publishes, and distributes interactive digital entertainment worldwide.
SNAL
US$1.09
7D
-12.8%
1Y
39.1%
Pyxis Tankers
Market Cap: US$29.4m
Operates as a maritime transportation company with a focus on the tanker and dry-bulk sectors in the United States and internationally.
PXS
US$2.80
7D
-4.9%
1Y
-43.0%
Performance Shipping
Market Cap: US$20.9m
Provides shipping transportation services through its tanker vessels worldwide.
PSHG
US$1.68
7D
-7.7%
1Y
-14.1%
Neuphoria Therapeutics
Market Cap: US$15.1m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$8.05
7D
-5.3%
1Y
n/a
Minerva Neurosciences
Market Cap: US$13.1m
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
NERV
US$1.91
7D
-10.2%
1Y
-34.1%
Sadot Group
Market Cap: US$8.5m
Provides supply chain solutions that address growing food security challenges worldwide.
SDOT
US$0.87
7D
-19.8%
1Y
-80.3%
Globavend Holdings
Market Cap: US$6.5m
Provides integrated cross-border logistics services, and air freight forwarding services in Hong Kong, Australia, and New Zealand.
GVH
US$5.14
7D
-28.6%
1Y
-95.9%